Table 1 Relevant medical history and interventions
Date | Summaries from Initial and Follow-up Visits | Diagnostic Testing | Interventions |
|---|---|---|---|
2015/11/20 | vision deteriorated(OS) | visual acuity (VA)20/20 (OD) and 20/32 (OS) | Â |
2015/11/24 | Still central scotoma (OS) | FA: hyperfluorescence (OS) and inflammation of retinal small vessels. OCT: parafoveal loss of the photoreceptor IS/OS junction | Dexamethasone 6Â mg daily |
2015/12/02 | Still central scotoma (OS) | stationary | Taper dexamethasone to 4Â mg daily, and add Amlodipine 5Â mg daily |
2015/12/15 | Still central scotoma (OS) | stationary | Intravitreal injection of Ozurdex. |
2015/12/30 | Vision improved (OS) | VA (OS) improved to 20/20 OCT: improvement of the IS/OS junction disruption | Â |
2017/01/18 | Vision stable(OS) | VA (OS) was 20/20 OCT: no sign of IS/OS junction disruption. | Â |